Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxatives, lipid lowering agents, mycolytic expectorants, and NSAIDs, as well as anti-inflammatory, narcotics, and multi-medicines. The company also exports its medicines to Afghanistan, Bhutan, Myanmar, Ivory Coast, Kenya, Mauritius, Somalia, Tanzania, Uganda. Silco Pharmaceuticals Limited was incorporated in 1995 and is headquartered in Sylhet, Bangladesh.
Metrics to compare | SILC | Peers Peers - average of corresponding metrics from companies closely matching SILC: CENTRALPHL, TECHNODRUG, IBP, SQURPHARMA, ORIONPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSILCPeersSector |
---|---|---|---|---|
P/E Ratio | 33.9x | 8.3x | −0.5x | |
PEG Ratio | 3.26 | 0.01 | 0.00 | |
Price/Book | 0.7x | 1.3x | 2.6x | |
Price / LTM Sales | 3.7x | 1.9x | 3.3x | |
Upside (Analyst Target) | - | 42.3% | 40.3% | |
Fair Value Upside | Unlock | 11.1% | 5.1% | Unlock |